Be a Smart Investor
Friday, April 12, 2019
TRACON Pharma Terminates Phase 3 TAPPAS Trial - Quick Facts
TRACON Pharmaceuticals, Inc. (TCON) announced Friday that its Phase 3 TAPPAS trial was terminated for futility based on the recommendation of the Independent Data Monitoring Committee (IDMC).
from RTT - Biotech http://bit.ly/2v6tBh3
via
IFTTT
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment